Pyxus International Q1 Earnings Call Highlights
Pyxus International reported first-quarter sales of $437.8 million, down from $508.8 million year over year, though gross margin rate improved to 14.0% from 12.9%.
Vaxart Q2 Earnings Call Highlights
Vaxart reported favorable 12-month safety data from its Phase II-B COVID-19 vaccine trial’s 400-person sentinel cohort, with top-line data from the larger 5,000-participant study expected in the first half of 2027.
LongHorn’s President Sold Darden Stock After a 9.5% Sales Jump. Here’s What to Know
Laura Williamson, president of LongHorn Steakhouse at Darden Restaurants, sold 1,553 shares on July 31 for approximately $317,557, while her steakhouse brand posted strong 9.5% comparable sales growth.
Olive Garden’s President Cashed In Options Struck at $124. Here’s What to Know
John W. Wilkerson, president of Olive Garden parent Darden Restaurants, sold 8,864 shares at $208.33 per share on August 5, exercising options struck at $124.24.
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly exceeded quarterly earnings and revenue expectations, raising its full-year guidance as sales of obesity drug Zepbound and diabetes treatment Mounjaro surged significantly.
Uber stock sinks 5% after weak guidance despite revenue growth
Uber shares dropped 5.3% after the ride-hailing company issued third-quarter guidance below analyst expectations, despite reporting stronger-than-expected second-quarter earnings and revenue growth.